Seraseq® PGT-A Trisomy 13 Reference Material

This product is discontinued as of 24 Aug 2025. For additional details, please refer to the discontinuation notice here.

Preimplantation genetic testing (PGT), or preimplantation genetic screening (PGS), both refer to the process of testing embryos prior to their transfer into a patient during an in vitro fertilization (IVF) cycle. The aim of the testing is to screen embryos for genetic anomalies and improve the odds of a successful pregnancy. Preimplantation genetic testing for chromosomal aneuploidies (PGT-A) is the most commonly used screening method.

LGC SeraCare now offers PGT-A reference materials for the most common trisomies - 21, 18, 13 along with euploid material which can be used as a negative control. These materials are:

• Formulated as genomic DNA from confirmed trisomic cells in buffer
• Offered at a concentration suitable for PGT-A
• Ideal for introduction to the PGT-A workflow at the WGA step
• Compatible with NGS-based PGT-A assays

Reproductive Health FAQs

Review the common questions we receive from our customers and the responses we provide.

LEARN MORE